Science Inventory

<< Previous

Next >>

Gallagher, K, W H. Benson, M. Brody, A Fairbrother, J. Hasan, R. Klaper, D L. Lattier, S. Lundquist, N. McCarroll, G. Miller, R J. Preston, P. Sayre, J. Seed, B. Smith, A. Street, R. Troast, V Vu*, L W. Reiter, AND K Dearfield. GENOMICS: CHALLENGES AND OPPORTUNITIES FOR THE U.S. ENVIRONMENTAL PROTECTION AGENCY. ENVIRONMENTAL HEALTH PERSPECTIVES 12(3):572-590, (2006).

AHLBORN, G., R. GRINDSTAFF, B. ROOP, J. W. ALLEN, G. M. NELSON, K. T. KITCHIN, D. J. THOMAS, C. J. WOLF, A. D. KLIGERMAN, A. H. TENNANT, G. W. KNAPP, J. PRESTON, W. M. WINNIK, AND D. A. DELKER. INVESTIGATIONS INTO AGE-RELATED SUSCEPTIBILITY TO ARSENIC CARCONOGENICITY. Presented at EPA Science Forum, Washington, DC, DC, May 15 - 18, 2006.

Au, W. W. AND R J. Preston. POPULATION MONITORING FOR ASSESSMENT OF HEALTH CONCERNS USING BIOMARKERS. Annual Review of Biomedical Sciences. São Paulo State University, , Brazil, 8:1-9, (2006).

Preston, R J. BYSTANDER EFFECTS, GENOMIC INSTABILITY, ADAPTIVE RESPONSE AND CANCER RISK ASSESSMENT FOR RADIATION AND CHEMICAL EXPOSURES. TOXICOLOGICAL AND APPLIED PHARMICOLOGY. Elsevier Science Ltd, New York, NY, 207(2):S550-S556, (2005).

PRESTON, J. CANCER RISK ASSESSMENT FOR 1,3 BUTADIENE: DATA INTEGRATION OPPORTUNITIES. Presented at 2005 International Symposium on Evaluation of Butadiene & Chloroprene Health Risks, Charleston, SC, September 20 - 22, 2005.

PRESTON, J. AND G. M. WILLIAMS. DNA-REACTIVE CARCINOGENS: MODE OF ACTION AND HUMAN CANCER HAZARD . CRITICAL REVIEWS IN TOXICOLOGY. CRC Press LLC, Boca Raton, FL, 35(8-9):673-683, (2005).

Mudipalli, A, R D. Owen, AND R J. Preston. EFFECT OF ARSENICALS ON ULTRAVIOLET-RADIATION-INDUCED GROWTH ARREST AND RELATED SIGNALING EVENTS IN HUMAN KERATINOCYTES. International Journal of Oncology. D.A. Spandidos, , Greece, 27(3):769-778, (2005).

PRESTON, J. INCORPORATION OF MOLECULAR ENDPOINTS INTO QUANTITATIVE RISK ASSESSMENT. Presented at International Conference on Environmental Mutagens, San Francisco, CA, September 05 - 09, 2005.

PRESTON, J., S. H. KOLLINS, J. M. SWANSON, L. L. GREENHILL, T. WIGAL, G. R. ELLIOT, AND B. VITIELLO. LETTER TO THE EDITOR - COMMENTS ON CYTOGENETIC EFFECTS IN CHILDREN TREATED WITH METHYLPHENIDATE. CANCER LETTERS. Elsevier Science Ltd, New York, NY, 230(2):292-294, (2005).

Preston, R J. MECHANISTIC DATA & CANCER RISK ASSESSMENT: THE NEED FOR QUANTITATIVE MOLECULAR ENDPOINTS. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS. Wiley Liss, New York, NY, 45(2-3):214-221, (2005).

SEED, J., E. CARNEY, R. CORLEY, K. M. CROFTON, J. M. DESESSO, P. FOSTER, R. J. KAVLOCK, G. L. KIMMEL, J. KLAUNIG, M. E. MEEK, J. PRESTON, W. SLIKKER, S. TABACOVA, G. M. WILLIAMS, J. WILTSE, R. T. ZOELLER, P. FENNER-CRISP, AND D. PATTON. OVERVIEW: USING MODE OF ACTION AND LIFE STAGE INFORMATION TO EVALUATE THE HUMAN RELEVANCE OF ANIMAL TOXICITY DATA. CRITICAL REVIEWS IN TOXICOLOGY. CRC Press LLC, Boca Raton, FL, 35:663-672, (2005).

PRESTON, J. THE SCIENCE BEHIND THE ICRP 2005 RECOMMENDATIONS. Presented at American Association for Physicists in Medicine 47th Annual Meeting, Seattle, WA, July 24 - 28, 2005.

PRESTON, J. THE USE OF STEM CELLS FOR TOXICOLOGY STUDIES AND RISK ASSESSMENTS. Presented at GEMS Spring Meeting, Research Triangle Park, NC, April 12, 2005.

Preston, R J. BYSTANDER EFFECTS GENOMIC INSTABILITY, ADAPTIVE RESPONSE AND CANCER RISK ASSESSMENT FOR RADIAION AND CHEMICAL EXPOSURES. Presented at 10th International Congress of Toxicology, Tampere, Finland, 07/11-15/04.

Preston, R J. CARCINOGENIC EFFECTS OF LOW DOSES OF IONIZING RADIATION. Presented at American Association for the Advancement of Science, Seattle, Washington, February 12-16, 2004.

Preston, R J. CHILDREN AS A SENSITIVE SUBPOPULATION FOR THE RISK ASSESSMENT PROCESS. TOXICOLOGY AND APPLIED PHARMACOLOGY 199(2):132-141, (2003).

Preston, R J. HISTORY OF GERM CELL MUTAGENESIS. Presented at Assessing Human Germ Cell Mutagenesis in the Post-Genome Era: A Celebration of the Legacy of Bill Russell, Bar Harbor, ME, September 28-30, 2004.

Barton, H A., H A. Tilson, R J. Preston, A D. Kligerman, L S. Birnbaum, J E. Simmons, J Vandenberg, Huang, YuhChin T, S J. Padilla, S Barone, R J. Kavlock, AND D J. Dix. HUMAN HEALTH RESEARCH IMPLEMENTATION PLAN, NATIONAL HEALTH AND ENVIRONMENTAL EFFECTS RESEARCH LABORATORY. U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-03/069 (NTIS PB2005-110709), 2003.

Preston, R J. RADIATION BIOLOGY: CONCEPTS FOR RADIATION PROTECTION. HEALTH PHYSICS. Lippincott Williams & Wilkins, Philadelphia, PA, 87(1):3-14, (2004).

Preston, R J. USE OF MECHANISTIC DATA TO HELP DEFINE DOSE-RESPONSE CURVES. Presented at Society of Toxicology, Baltimore, MD, 03/21-25/04.

Preston, R J. BYSTANDERS, ADAPTIVE RESPONSES AND GENOMIC INSTABILITY - POTENTIAL MODIFIERS OF LOW-DOSE CANCER RESPONSES. . Presented at Society of Toxicology 42nd. Annual Meeting, Salt Lake City, Utah, March 9-13, 2003.

Brenner, D. J., R. Doll, D. T. Goodhead, E. J. Hall, C. E. Land, J. B. Little, J. H. Lubin, D. L. Preston, R J. Preston, J. S. Puskin, E. Ron, R. K. Sachs, J. M. Samet, R. B. Setlow, AND M. Zaider. CANCER RISKS ATTRIBUTABLE TO LOW DOSES OF IONIZING RADIATION - ASSESSING WHAT WE REALLY KNOW? PNAS (PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES) 100(24):13761-13766, (2003).

Preston, R J. DEVELOPING MECHANISTIC DATA FOR INCORPORATION INTO CANCER AND GENETIC RISK ASSESSMENTS: OLD PROBLEMS AND NEW APPROACHES. HEALTH PHYSICS 85(1):4-12, (2003).

Allen, J W., C F. Blackman, M. J. Blaze, D. A. Delker, D M. DeMarini, C L. Doerr, R D. Grindstaff, S D. Hester, C. P. Jones, A D. Kligerman, G W. Knapp, M. J. Kohan, G M. Nelson, R. D. Owen, R J. Preston, B C. Roop, A H. Tennant, S. F. Thai, E. Winkfield, W. M. Winnik, D C. Wolf, AND R R. Rogers. DEVELOPMENT OF MOLECULAR MARKERS OF RESPONSE TO ASSESS THE SENSITIVITY OF CHILDREN TO ENVIRONMENTAL CHEMICALS. Presented at National Children's Study Assembly, Atlanta, GA, 12/17/03.

Mudipalli, A, R D. Owen, AND R J. Preston. EFFECT OF ARSENICALS ON THE EXPRESSION OF CELL CYCLE PROTEINS AND EARLY SIGNALING EVENTS IN PRIMARY HUMAN KERATINOCYTES. Presented at 94th American Assoc. of Cancer Research, Washington, DC, 07/11-14/03.